"Complement Pathway, Alternative/genetics"[MeSH] - Search Results

Year	Number of Results
1990	2
1991	3
1992	1
1993	2
1995	1
1996	3
1999	4
2000	4
2001	4
2002	2
2003	1
2004	3
2005	1
2006	7
2007	9
2008	8
2009	5
2010	13
2011	12
2012	16
2013	12
2014	14
2015	8
2016	15
2017	9
2018	18
2019	5
2020	11
2021	6
2022	9
2023	8
2024	0

1

Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.

Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Raina R, et al. Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29. Ther Apher Dial. 2019. PMID: 30294946 Review.

2

Alternative pathway diagnostics.

Thurman JM, Fremeaux-Bacchi V. Thurman JM, et al. Immunol Rev. 2023 Jan;313(1):225-238. doi: 10.1111/imr.13156. Epub 2022 Oct 28. Immunol Rev. 2023. PMID: 36305168 Free PMC article. Review.

3

Atypical hemolytic-uremic syndrome.

Noris M, Remuzzi G. Noris M, et al. N Engl J Med. 2009 Oct 22;361(17):1676-87. doi: 10.1056/NEJMra0902814. N Engl J Med. 2009. PMID: 19846853 Review. No abstract available.

4

The role of the alternative pathway of complement activation in glomerular diseases.

Łukawska E, Polcyn-Adamczak M, Niemir ZI. Łukawska E, et al. Clin Exp Med. 2018 Aug;18(3):297-318. doi: 10.1007/s10238-018-0491-8. Epub 2018 Feb 15. Clin Exp Med. 2018. PMID: 29450785 Review.

5

The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome.

Crovetto F, Borsa N, Acaia B, Nishimura C, Frees K, Smith RJ, Peyvandi F, Palla R, Cugno M, Tedeschi S, Castorina P, Somigliana E, Ardissino G, Fedele L. Crovetto F, et al. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2322-5. doi: 10.3109/14767058.2012.694923. Epub 2012 Jun 7. J Matern Fetal Neonatal Med. 2012. PMID: 22594569

6

AMD and the alternative complement pathway: genetics and functional implications.

Tan PL, Bowes Rickman C, Katsanis N. Tan PL, et al. Hum Genomics. 2016 Jun 21;10(1):23. doi: 10.1186/s40246-016-0079-x. Hum Genomics. 2016. PMID: 27329102 Free PMC article. Review.

7

Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases.

Rodríguez de Córdoba S. Rodríguez de Córdoba S. Immunol Rev. 2023 Jan;313(1):71-90. doi: 10.1111/imr.13131. Epub 2022 Sep 11. Immunol Rev. 2023. PMID: 36089777 Free PMC article. Review.

8

Novel Functional Assay to Characterize Mutations in Alternative Pathway of Complement.

Gerber GF, Pan XZ, Lederman HM, Brady TM, Brodsky RA. Gerber GF, et al. J Clin Immunol. 2023 Aug;43(6):1134-1136. doi: 10.1007/s10875-023-01496-6. Epub 2023 Apr 26. J Clin Immunol. 2023. PMID: 37099066 No abstract available.

9

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Noris M, Donadelli R, Remuzzi G. Noris M, et al. Pediatr Nephrol. 2019 Aug;34(8):1311-1323. doi: 10.1007/s00467-018-3989-0. Epub 2018 Jun 9. Pediatr Nephrol. 2019. PMID: 29948306 Review.

10

Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.

Parsons NB, Annamalai B, Rohrer B. Parsons NB, et al. Transl Vis Sci Technol. 2023 Jul 3;12(7):17. doi: 10.1167/tvst.12.7.17. Transl Vis Sci Technol. 2023. PMID: 37462980 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

186 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year